Standout Papers

Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias 2006 2026 2012 2019 1.3k
  1. Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias (2006)
    Moshe Talpaz, Neil P. Shah et al. New England Journal of Medicine
  2. Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (2010)
    Hagop M. Kantarjian, Neil P. Shah et al. New England Journal of Medicine

Citation Impact

1 by Nobel laureates 24 from Science/Nature 70 standout
Sub-graph 1 of 19

Citing Papers

Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial
2024 Standout
A view on drug resistance in cancer
2019 StandoutNature
1 intermediate paper

Works of Eric Bleickardt being referenced

Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
2010 Standout
Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias
2006 Standout

Author Peers

Author Hematology Genetics Rheumatology Last Decade Papers Cites
Eric Bleickardt 3254 2368 1609 39 3.9k
Raymond E. Cline 12 1.2k
L. R. Dodd 30 509
Ning Ding 1 22 343
Antonia Calligaro 221 21 473 36 653
Janine Olesch 2 7 138

All Works

Loading papers...

Rankless by CCL
2026